Follow‐up of late‐onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles

BACKGROUND: Late‐onset Pompe disease (LOPD) is a genetic disorder characterized by progressive degeneration of the skeletal muscles produced by a deficiency of the enzyme acid alpha‐glucosidase. Enzymatic replacement therapy with recombinant human alpha‐glucosidase seems to reduce the progression of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nuñez‐Peralta, Claudia, Alonso‐Pérez, Jorge, Llauger, Jaume, Segovia, Sonia, Montesinos, Paula, Belmonte, Izaskun, Pedrosa, Irene, Montiel, Elena, Alonso‐Jiménez, Alicia, Sánchez‐González, Javier, Martínez‐Noguera, Antonio, Illa, Isabel, Díaz‐Manera, Jordi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432562/
https://www.ncbi.nlm.nih.gov/pubmed/32129012
http://dx.doi.org/10.1002/jcsm.12555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432562/
https://www.ncbi.nlm.nih.gov/pubmed/32129012
http://dx.doi.org/10.1002/jcsm.12555

Ejemplares similares